HC Wainwright Reaffirms Buy Rating for Milestone Pharmaceuticals (NASDAQ:MIST)
Milestone Pharmaceuticals (NASDAQ:MIST – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a report issued on Monday,Benzinga reports. They currently have a $25.00 price target on the stock. Milestone Pharmaceuticals Price Performance MIST stock opened at $2.38 on Monday. The company has a quick ratio of 15.40, […]
